Loading
IARC estimates 6,015 new cancer cases and 2,680 cancer deaths in Cyprus in 2024; the commonest new cancers are breast, prostate and thyroid. This page is assembled automatically from OnCo's data: 1 trial with a site there, 2 institutions and 2 people, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 1,004 | 92.9 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Prostate | 709 | 57.9 | Prostate cancer |
| Thyroid | 626 | 34.7 | Thyroid cancer |
| Trachea, bronchus and lung | 605 | 25.1 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Colorectum | 572 | 22.5 | Colorectal cancer |
| Bladder | 336 | 13.1 | Bladder & urothelial cancer |
| Non-Hodgkin lymphoma | 246 | 11.8 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Leukaemia | 219 | 10.8 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Pancreas | 205 | 8.3 | Pancreatic ductal adenocarcinoma |
| Corpus uteri | 186 | 16.5 | Endometrial cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Trachea, bronchus and lung | 510 | 20.4 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Colorectum | 331 | 11.6 | Colorectal cancer |
| Breast | 213 | 15.9 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Pancreas | 194 | 7.5 | Pancreatic ductal adenocarcinoma |
| Prostate | 176 | 11.5 | Prostate cancer |
| Leukaemia | 147 | 5.1 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Bladder | 114 | 3.7 | Bladder & urothelial cancer |
| Stomach | 112 | 4.2 | Gastric & gastro-oesophageal junction cancer |
| Brain, central nervous system | 103 | 4.5 | Glioma & glioblastoma |
| Non-Hodgkin lymphoma | 93 | 3.4 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Trial | Lead sponsor | ||||
|---|---|---|---|---|---|
EORTC 22991 NCT00021450 | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 20 | 2016-09-02 |
Trial records in OnCo whose ClinicalTrials.gov entry lists at least one site in Cyprus, captured 2026-10-07 to 2026-10-07. Recruiting first, then the most recently updated. The status is the study's overall status; whether a site in Cyprus is open is on the registry page, under Contacts and Locations.
People whose main affiliation in OnCo is an institution or company in Cyprus.
Cyprus is an EU member state, so an EU centralised authorisation covers it: 309 products in OnCo carry a sourced EU row that is approved or conditional. See the approvals by region matrix. National procedures and reimbursement are not recorded.
Cyprus is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.